Tissue distribution of 2-methoxyestradiol nanosuspension in rats and its antitumor activity in C57BL/6 mice bearing lewis lung carcinoma. 2012

Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
School of Chemical Engineering and Energy, Zhengzhou University, Zhengzhou, PR China.

The purpose of the present study was to evaluate the tissue distribution and antitumor activity of 2-methoxyestradiol (2-ME) nanosuspension compared with 2-ME solution both in vitro and in vivo. 2-ME nanosuspension was made by nanoprecipitation-high-frequency ultrasonication method with the particle size of 168.4 ± 3.2 nm and the zeta potential of -29.79 ± 1.89 mV. The overall targeting efficiency (TE(Q)) of 2-ME nanosuspension was improved from 28.71 to 51.95% in the lung of rats. MTT assay showed that 2-ME nanosuspension could significantly enhance the in vitro cytotoxicity against lewis lung carcinoma (LLC) cells compared with the 2-ME solution, the IC(50) at 72 h was reduced from 6.35 µM for 2-ME solution to 3.56 µM for 2-ME nanosuspension. The antitumor activity in vivo was investigated in C57BL/6 mice bearing LLC, and the results indicated that 2-ME nanosuspension not only exhibited significant suppression of the tumor growth when compared with that of positive group or cyclophosphamide group at the same dose, but also enhanced the spleen indices. Overall, 2-ME nanosuspension could mainly deliver the drug to lungs and made the drug accumulate in the lungs, so 2-ME nanosuspension has a possible lung cancer therapeutic potential.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D000077584 2-Methoxyestradiol A metabolite of estradiol that lacks estrogenic activity and inhibits TUBULIN polymerization. It has antineoplastic properties, including inhibition of angiogenesis and induction of APOPTOSIS. (17 beta)-2-methoxyestra-1,3,5(10)-triene-3,17-diol,2-(methyl-11C)Methoxyestradiol,2-Methoxyestradiol, (17alpha)-isomer,2-Methoxyestradiol-17 beta,2-Methoxyoestradiol,Panzem,2 Methoxyestradiol,2 Methoxyestradiol 17 beta,2 Methoxyoestradiol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013535 Suspensions Colloids with liquid continuous phase and solid dispersed phase; the term is used loosely also for solid-in-gas (AEROSOLS) and other colloidal systems; water-insoluble drugs may be given as suspensions. Suspension
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
April 2012, Drug development and industrial pharmacy,
Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
December 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
June 1987, Journal of pharmacobio-dynamics,
Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
August 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
January 1991, Journal of leukocyte biology,
Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
January 1980, Pharmacological research communications,
Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
November 1979, Life sciences,
Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
September 2020, Bioorganic & medicinal chemistry letters,
Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
January 1984, Progress in clinical and biological research,
Guopeng Shen, and Qingyu Wang, and Qingqing Zhang, and Huibin Sun, and Ya Zhao, and Zhenzhong Zhang, and Bin Du
June 1983, Cancer treatment reports,
Copied contents to your clipboard!